Last week’s hot topic on pulmonary hypertension was New PAH Drug Delivery System Receives EC Certification written by Margarida Azevedo.
This article is about clinical-stage biotherapeutics company, Bellerophon Therapeutics, Inc., which recently announced that its proprietary program device, a new version of the INOpulse drug-device delivery system, has received EC certification with CE marking, meaning that it has met the European Union’s regulatory health, safety, and environmental requirements for a new medical device and can be marketed in Europe.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?